Safety of COVID-19 mRNA Vaccination Among Young Children in the Vaccine Safety Datalink
Pediatrics
.
2023 Jul 1;152(1):e2023061894.
doi: 10.1542/peds.2023-061894.
Authors
Kristin Goddard
1
,
James G Donahue
2
,
Ned Lewis
1
,
Kayla E Hanson
2
,
Eric S Weintraub
3
,
Bruce Fireman
1
,
Nicola P Klein
1
Affiliations
1
Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California, Oakland, California.
2
Marshfield Clinic Research Institute, Marshfield, Wisconsin.
3
Immunization Safety Office, Centers for Disease Control and Prevention, Atlanta, Georgia.
PMID:
37278199
PMCID:
PMC10468817
DOI:
10.1542/peds.2023-061894
No abstract available
MeSH terms
COVID-19 Vaccines / adverse effects
COVID-19* / prevention & control
Child
Child, Preschool
Humans
RNA, Messenger
Vaccination / adverse effects
Vaccines*
Substances
RNA, Messenger
Vaccines
COVID-19 Vaccines
Grants and funding
CC999999/ImCDC/Intramural CDC HHS/United States